What's breaking now, across thousands of outlets.
A year ago, Endpoints Signal surveyed almost 1,500 biopharma insiders about the very near-term prospects of AI accelerating drug discovery. Scientists, interestingly, were the most skeptical. Now, as we revisit the question in our
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Marcelle Flowers was trying to sell her Sacramento business when Broccoli AI knocked on her door. Now they've raised $52 million led by Khosla Ventures.
An agent receives approval to process a partial refund. It sends the request to a payment API, and the process The post AI agents need to be replaceable – without losing your work appeared first on…
Most AI drug development firms are focused on discovery. AI biotech Formation Bio is betting the real bottleneck is clinical trials.
Enterprise artificial intelligence context startup Jedify Inc. today formally launched Data Agents, a product that lets business teams set up autonomous AI analysts by describing the work they want…
Anthropic released early results from drug development work with six partners, including Bristol Myers Squibb
Enthusiasm for artificial intelligence agents is at an all-time high and many enterprises have gotten so carried away that they’re deploying them faster than they keep up.
